Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sight Sciences (SGHT)
NASDAQ:SGHT
Sight Sciences (SGHT) Stock Price & Analysis
71 Followers
SGHT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.04 - $9.31
Previous Close$6.16
Volume76.06K
Average Volume (3M)166.85K
Market Cap
$306.50M
Enterprise Value$202.30M
Total Cash (Recent Filing)$138.13M
Total Debt (Recent Filing)$33.93M
Price to Earnings (P/E)―
Beta2.34
Next Earnings
Aug 08, 2024EPS Estimate
-$0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.12
Shares Outstanding49,756,252
10 Day Avg. Volume101,406
30 Day Avg. Volume166,855
Standard Deviation0.32
R-Squared0.21
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.64
Price to Sales (P/S)16.93
Price to Cash Flow (P/CF)-12.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.50
Enterprise Value/Gross Profit2.92
Enterprise Value/Ebitda-5.36
Forecast
1Y Price Target
$5.70Price Target Upside-7.92% Downside
Rating ConsensusHold
Number of Analyst Covering3
Sight Sciences News
Bulls Say, Bears Say
Bulls Say
Financial ForecastAnalyst highlights that SGHT's management anticipates a rebound to double-digit revenue growth in the second half of the year, which is expected to carry forward.
Product ReimbursementManagement's belief that TearCare will likely receive reimbursement coverage could signal a significant boost to the company's financial health.
Regulatory ReliefThe decision by Medicare Administrative Contractors to maintain coverage for SGHT's OMNI device is a positive turn of events, eliminating concerns over potential repayment obligations.
Bears Say
Reimbursement IssuesCanaloplasty reimbursement remains an overhang
Reimbursement UncertaintyOMNI's reimbursement status could remain an overhang due to expectations of a reconfigured LCD being proposed in the near-term.
Stock ValuationAnalyst believes the near-term upside for SGHT's stock is already priced in due to prior notice of the LCD withdrawal.
---
Ownership Overview
54.00% Insiders
10.58% Mutual Funds
12.66% Other Institutional Investors
22.76% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SGHT FAQ
What was Sight Sciences’s price range in the past 12 months?
Sight Sciences lowest stock price was $1.04 and its highest was $9.31 in the past 12 months.
What is Sight Sciences’s market cap?
Currently, no data Available
When is Sight Sciences’s upcoming earnings report date?
Sight Sciences’s upcoming earnings report date is Aug 08, 2024 which is in 34 days.
How were Sight Sciences’s earnings last quarter?
Sight Sciences released its earnings results on May 02, 2024. The company reported -$0.33 earnings per share for the quarter, missing the consensus estimate of -$0.276 by -$0.054.
Is Sight Sciences overvalued?
According to Wall Street analysts Sight Sciences’s price is currently Overvalued.
Does Sight Sciences pay dividends?
Sight Sciences does not currently pay dividends.
What is Sight Sciences’s EPS estimate?
Sight Sciences’s EPS estimate is -$0.3.
How many shares outstanding does Sight Sciences have?
Sight Sciences has 49,756,252 shares outstanding.
What happened to Sight Sciences’s price movement after its last earnings report?
Sight Sciences reported an EPS of -$0.33 in its last earnings report, missing expectations of -$0.276. Following the earnings report the stock price went up 6.239%.
Which hedge fund is a major shareholder of Sight Sciences?
Among the largest hedge funds holding Sight Sciences’s share is First Eagle Investment Management LLC. It holds Sight Sciences’s shares valued at N/A.
---
Sight Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.70 (-7.92% Downside)
$5.70 (-7.92% Downside)
Blogger Sentiment
Bullish
SGHT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 6.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $462.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-25.60%
12-Months-Change
Fundamentals
Return on Equity
-42.84%
Trailing 12-Months
Asset Growth
-20.89%
Trailing 12-Months
Company Description
Sight Sciences
Sight Sciences Inc is a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease. The company's product portfolio features the OMNI Surgical System, a dually-indicated device that facilitates the performance of both trabeculotomy and viscoelastic delivery. The company's non-surgical product portfolio consists of TearCare system which is commercially available for both ophthalmologists and optometrists.
---
SGHT Company Deck
---
SGHT Earnings Call
Q1 2024
0:00 / 0:00
---
SGHT Stock 12 Month Forecast
Average Price Target
$5.70
▼(-7.92% Downside)
Technical Analysis
Best Analysts Covering SGHT
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+39.60%
assigned a buy rating 4 months ago
Copying Thomas Stephan's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +39.60% per trade.
---